Metabolomics for predicting fetal growth restriction: protocol for a systematic review and meta-analysis

Thumbnail Image
Leite, Debora Farias Batista
Morillon, Aude-Claire
Melo Júnior, Elias F.
Souza, Renato T.
Khashan, Ali S.
Baker, Philip N.
Kenny, Louise C.
Cecatti, José Guilherme
Journal Title
Journal ISSN
Volume Title
BMJ Publishing Group
Research Projects
Organizational Units
Journal Issue
Introduction Fetal growth restriction (FGR) is a relevant research and clinical concern since it is related to higher risks of adverse outcomes at any period of life. Current predictive tools in pregnancy (clinical factors, ultrasound scan, placenta-related biomarkers) fail to identify the true growth-restricted fetus. However, technologies based on metabolomics have generated interesting findings and seem promising. In this systematic review, we will address diagnostic accuracy of metabolomics analyses in predicting FGR.Methods and analysis Our primary outcome is small for gestational age infant, as a surrogate for FGR, defined as birth weight below the 10th centile by customised or population-based curves for gestational age. A detailed systematic literature search will be carried in electronic databases and conference abstracts, using the keywords ‘fetal growth retardation’, ‘metabolomics’, ‘pregnancy’ and ‘screening’ (and their variations). We will include original peer-reviewed articles published from 1998 to 2018, involving pregnancies of fetuses without congenital malformations; sample collection must have been performed before clinical recognition of growth impairment. If additional information is required, authors will be contacted. Reviews, case reports, cross-sectional studies, non-human research and commentaries papers will be excluded. Sample characteristics and the diagnostic accuracy data will be retrieved and analysed. If data allows, we will perform a meta-analysis.Ethics and dissemination As this is a systematic review, no ethical approval is necessary. This protocol will be publicised in our institutional websites and results will be submitted for publication in a peer-reviewed journal.PROSPERO registration number CRD42018089985.
Fetal growth restriction , Pregnancy , Metabolomics
Leite, D.F.B., Morillon, A.C., Júnior, E.F.M., Souza, R.T., Khashan, A.S., Baker, P.N., Kenny, L.C. and Cecatti, J.G., 2018. Metabolomics for predicting fetal growth restriction: protocol for a systematic review and meta-analysis. BMJ open, 8(12), (e022743) DOI: 10.1136/bmjopen-2018-022743